IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Synergy Pharmaceuticals Inc

CUSIP: 871639308 | 410 institutional holders

Quarters

Q1 2025Q4 2024Q3 2024Q2 2024Q3 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2025

1620 Investment Advisors, Inc.25
0.0% of portfolio›$0
StyleTurnoverLocationFiled
1620 Investment Advisors, Inc.
25$00.0%ValueLowPlymouth, MA2025-05-14